{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T20:19:28Z","timestamp":1782937168376,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272863"],"award-info":[{"award-number":["82272863"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","award":["2024KF0228"],"award-info":[{"award-number":["2024KF0228"]}],"id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Yishan Research Project of Jiangsu Cancer Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>KRAS-mutant lung adenocarcinoma (LUAD), due to its evolution of more complex antioxidant metabolic mechanisms, exhibits poorer sensitivity to conventional platinum-based drugs compared to other types of LUAD. Ferroptosis, as a means of inducing cell death in cancer therapy, shows unique features and potential therapeutic effects compared to the conventional form of apoptosis, which is frequently obstructed by drug resistance. In human KRAS-mutant LUAD cell lines and mouse models, we found that the deubiquitinase OTU deubiquitinase 7A (OTUD7A) precisely regulates the lysine demethylase 5B (KDM5B). Inhibition of KDM5B expression increases the H4K20me3 level, which in turn downregulates the expression of transcription factor GABPA associated with mitochondrial function, ultimately promoting the production of more Reactive Oxygen Species (ROS) by mitochondria and inducing ferroptosis. Additionally, in in vivo organoid models, cisplatin (CDDP) induced ferroptosis combined with GABPA inhibition demonstrated superior anticancer effects compared to conventional platinum-based drugs. This research identifies new targets and regulatory networks that hold promise for developing ferroptosis-based therapies for KRAS-mutant LUAD.<\/jats:p>","DOI":"10.1038\/s41419-025-08337-x","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T09:34:12Z","timestamp":1766223252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Suppressing the OTUD7A\/KDM5B\/GABPA axis enhances the sensitivity of cisplatin through inducing ferroptosis in KRAS-mutant LUAD"],"prefix":"10.1038","volume":"17","author":[{"given":"Rujia","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6923-8338","authenticated-orcid":false,"given":"Ziyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8681-6519","authenticated-orcid":false,"given":"Ying","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6569-5956","authenticated-orcid":false,"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8782-3151","authenticated-orcid":false,"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"8337_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"8337_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","volume":"19","author":"SR Punekar","year":"2022","unstructured":"Punekar SR, Velcheti V, Neel BG, Wong K-K. The current state of the art and future trends in RAS-targeted cancer therapies. Nat Rev Clin Oncol. 2022;19:637\u201355. https:\/\/doi.org\/10.1038\/s41571-022-00671-9.","journal-title":"Nat Rev Clin Oncol"},{"key":"8337_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","volume":"575","author":"J Canon","year":"2019","unstructured":"Canon J, Rex K, Saiki AY, Mohr C, Cooke K, Bagal D, et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019;575:217\u201323. https:\/\/doi.org\/10.1038\/s41586-019-1694-1.","journal-title":"Nature"},{"key":"8337_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354. https:\/\/doi.org\/10.1038\/nature25183.","journal-title":"Nature"},{"key":"8337_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","volume":"34","author":"LE Hendriks","year":"2023","unstructured":"Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, et al. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2730. Ann Oncol. 2023;34:339\u201357. https:\/\/doi.org\/10.1016\/j.annonc.2022.12.009.","journal-title":"Ann Oncol"},{"key":"8337_CR6","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","volume":"80","author":"IA Prior","year":"2020","unstructured":"Prior IA, Hood FE, Hartley JL. The frequency of Ras mutations in cancer. Cancer Res. 2020;80:2969\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3682.","journal-title":"Cancer Res"},{"key":"8337_CR7","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.15252\/embr.201541113","volume":"16","author":"E Dimitrova","year":"2015","unstructured":"Dimitrova E, Turberfield AH, Klose RJ. Histone demethylases in chromatin biology and beyond. EMBO Rep. 2015;16:1620\u201339. https:\/\/doi.org\/10.15252\/embr.201541113.","journal-title":"EMBO Rep"},{"key":"8337_CR8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1158\/2159-8290.CD-22-0825","volume":"13","author":"K Gunn","year":"2023","unstructured":"Gunn K, Myllykoski M, Cao JZ, Ahmed M, Huang B, Rouaisnel B. et al. (R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers. Cancer Discov. 2023;13:1478\u20131497. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0825.","journal-title":"Cancer Discov"},{"key":"8337_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35059-x","volume":"13","author":"A Verma","year":"2022","unstructured":"Verma A, Singh A, Singh MP, Nengroo MA, Saini KK, Satrusal SR, et al. EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis. Nat Commun. 2022;13:7344. https:\/\/doi.org\/10.1038\/s41467-022-35059-x.","journal-title":"Nat Commun"},{"key":"8337_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41588-022-01047-6","volume":"54","author":"J Marsolier","year":"2022","unstructured":"Marsolier J, Prompsy P, Durand A, Lyne A-M, Landragin C, Trouchet A, et al. H3K27me3 conditions chemotolerance in triple-negative breast cancer. Nat Genet. 2022;54:459\u201368. https:\/\/doi.org\/10.1038\/s41588-022-01047-6.","journal-title":"Nat Genet"},{"key":"8337_CR11","doi-asserted-by":"publisher","unstructured":"Gou, D, Liu, R, Shan, X, Deng, H, Chen, C, Xiang, J, et al. Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression. J Clin Invest 2023. https:\/\/doi.org\/10.1172\/JCI161713.","DOI":"10.1172\/JCI161713"},{"key":"8337_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-021-03994-2","volume":"598","author":"S-M Zhang","year":"2021","unstructured":"Zhang S-M, Cai WL, Liu X, Thakral D, Luo J, Chan LH, et al. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. Nature. 2021;598:682\u20137. https:\/\/doi.org\/10.1038\/s41586-021-03994-2.","journal-title":"Nature"},{"key":"8337_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.semcancer.2018.11.001","volume":"57","author":"B Xhabija","year":"2019","unstructured":"Xhabija B, Kidder BL. KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer. Semin Cancer Biol. 2019;57:79\u201385. https:\/\/doi.org\/10.1016\/j.semcancer.2018.11.001.","journal-title":"Semin Cancer Biol"},{"key":"8337_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41418-024-01257-x","volume":"31","author":"B Zhang","year":"2024","unstructured":"Zhang B, Li J, Wang Y, Liu X, Yang X, Liao Z, et al. Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16\/TOP2A axis. Cell Death Differ. 2024;31:309\u201321. https:\/\/doi.org\/10.1038\/s41418-024-01257-x.","journal-title":"Cell Death Differ"},{"key":"8337_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41418-023-01136-x","volume":"30","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Gao Y, Jiang Y, Ding Y, Chen H, Xiang Y, et al. Histone demethylase KDM5B licenses macrophage-mediated inflammatory responses by repressing Nfkbia transcription. Cell Death Differ. 2023;30:1279\u201392. https:\/\/doi.org\/10.1038\/s41418-023-01136-x.","journal-title":"Cell Death Differ"},{"key":"8337_CR16","doi-asserted-by":"publisher","first-page":"19226","DOI":"10.1073\/pnas.0700735104","volume":"104","author":"Y Xiang","year":"2007","unstructured":"Xiang Y, Zhu Z, Han G, Ye X, Xu B, Peng Z, et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci USA. 2007;104:19226\u201331. https:\/\/doi.org\/10.1073\/pnas.0700735104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8337_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-59","volume":"9","author":"S Hayami","year":"2010","unstructured":"Hayami S, Yoshimatsu M, Veerakumarasivam A, Unoki M, Iwai Y, Tsunoda T, et al. Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F\/RB pathway. Mol Cancer. 2010;9:59. https:\/\/doi.org\/10.1186\/1476-4598-9-59.","journal-title":"Mol Cancer"},{"key":"8337_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148. https:\/\/doi.org\/10.1186\/s12943-024-02046-3.","journal-title":"Mol Cancer"},{"key":"8337_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen S-H, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28:591\u2013605. https:\/\/doi.org\/10.1038\/s41418-020-00708-5.","journal-title":"Cell Death Differ"},{"key":"8337_CR20","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20:1242\u201353. https:\/\/doi.org\/10.1038\/nm.3739.","journal-title":"Nat Med"},{"key":"8337_CR21","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn PJA, Komander D. Deubiquitinases in cancer. Nat Rev Cancer. 2023;23:842\u201362. https:\/\/doi.org\/10.1038\/s41568-023-00633-y.","journal-title":"Nat Rev Cancer"},{"key":"8337_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"key":"8337_CR23","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1038\/s41388-022-02311-z","volume":"41","author":"R He","year":"2022","unstructured":"He R, Xhabija B, Gopi LK, Kurup JT, Xu Z, Liu Z, et al. H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity. Oncogene. 2022;41:2958\u201372. https:\/\/doi.org\/10.1038\/s41388-022-02311-z.","journal-title":"Oncogene"},{"key":"8337_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/ijbs.25881","volume":"14","author":"W Xu","year":"2018","unstructured":"Xu W, Zhou B, Zhao X, Zhu L, Xu J, Jiang Z, et al. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance. Int J Biol Sci. 2018;14:1122\u201332. https:\/\/doi.org\/10.7150\/ijbs.25881.","journal-title":"Int J Biol Sci"},{"key":"8337_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r32","volume":"15","author":"BL Kidder","year":"2014","unstructured":"Kidder BL, Hu G, Zhao K. KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation. Genome Biol. 2014;15:R32. https:\/\/doi.org\/10.1186\/gb-2014-15-2-r32.","journal-title":"Genome Biol"},{"key":"8337_CR26","doi-asserted-by":"publisher","first-page":"e1005116","DOI":"10.1371\/journal.pgen.1005116","volume":"11","author":"YK Kang","year":"2015","unstructured":"Kang YK, Putluri N, Maity S, Tsimelzon A, Ilkayeva O, Mo Q, et al. CAPER is vital for energy and redox homeostasis by integrating glucose-induced mitochondrial functions via ERR-\u03b1-Gabpa and stress-induced adaptive responses via NF-\u03baB-cMYC. PLoS Genet. 2015;11:e1005116 https:\/\/doi.org\/10.1371\/journal.pgen.1005116.","journal-title":"PLoS Genet"},{"key":"8337_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102353","volume":"98","author":"M George","year":"2024","unstructured":"George M, Reddy AP, Reddy PH, Kshirsagar S. Unraveling the NRF2 confusion: distinguishing nuclear respiratory factor 2 from nuclear erythroid factor 2. Ageing Res Rev. 2024;98:102353. https:\/\/doi.org\/10.1016\/j.arr.2024.102353.","journal-title":"Ageing Res Rev"},{"key":"8337_CR28","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ymthe.2024.02.029","volume":"32","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhang H, Hong G, Bi X, Hu J, Zhang T, et al. Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL\/6 mice. Mol Ther. 2024;32:1387\u2013406. https:\/\/doi.org\/10.1016\/j.ymthe.2024.02.029.","journal-title":"Mol Ther"},{"key":"8337_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res Treat. 2018;50:445\u201360. https:\/\/doi.org\/10.4143\/crt.2016.572.","journal-title":"Cancer Res Treat"},{"key":"8337_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.gendis.2020.09.005","volume":"9","author":"L Wang","year":"2022","unstructured":"Wang L, Chen X, Yan C. Ferroptosis: an emerging therapeutic opportunity for cancer. Genes Dis. 2022;9:334\u201346. https:\/\/doi.org\/10.1016\/j.gendis.2020.09.005.","journal-title":"Genes Dis"},{"key":"8337_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41422-023-00788-1","volume":"33","author":"S Qiu","year":"2023","unstructured":"Qiu S, Zhong X, Meng X, Li S, Qian X, Lu H, et al. Mitochondria-localized cGAS suppresses ferroptosis to promote cancer progression. Cell Res. 2023;33:299\u2013311. https:\/\/doi.org\/10.1038\/s41422-023-00788-1.","journal-title":"Cell Res"},{"key":"8337_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jare.2023.02.012","volume":"55","author":"Y Bi","year":"2024","unstructured":"Bi Y, Liu S, Qin X, Abudureyimu M, Wang L, Zou R, et al. FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury in a mitophagy-dependent manner. J Adv Res. 2024;55:45\u201360. https:\/\/doi.org\/10.1016\/j.jare.2023.02.012.","journal-title":"J Adv Res"},{"key":"8337_CR33","doi-asserted-by":"publisher","first-page":"e132747","DOI":"10.1172\/jci.insight.132747","volume":"5","author":"T Tadokoro","year":"2020","unstructured":"Tadokoro T, Ikeda M, Ide T, Deguchi H, Ikeda S, Okabe K, et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. 2020;5:e132747\u2013132747. https:\/\/doi.org\/10.1172\/jci.insight.132747.","journal-title":"JCI Insight"},{"key":"8337_CR34","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1073\/pnas.1003428107","volume":"107","author":"F Weinberg","year":"2010","unstructured":"Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA. 2010;107:8788\u201393. https:\/\/doi.org\/10.1073\/pnas.1003428107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8337_CR35","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature16967","volume":"531","author":"EM Kerr","year":"2016","unstructured":"Kerr EM, Gaude E, Turrell FK, Frezza C, Martins CP. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities. Nature. 2016;531:110\u20133. https:\/\/doi.org\/10.1038\/nature16967.","journal-title":"Nature"},{"key":"8337_CR36","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1126\/science.1174229","volume":"325","author":"J Yun","year":"2009","unstructured":"Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science. 2009;325:1555\u20139. https:\/\/doi.org\/10.1126\/science.1174229.","journal-title":"Science"},{"key":"8337_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475:106\u20139. https:\/\/doi.org\/10.1038\/nature10189.","journal-title":"Nature"},{"key":"8337_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s43018-021-00184-x","volume":"2","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay S, Vander Heiden MG, McCormick F. The metabolic landscape of RAS-driven cancers from biology to therapy. Nat Cancer. 2021;2:271\u201383. https:\/\/doi.org\/10.1038\/s43018-021-00184-x.","journal-title":"Nat Cancer"},{"key":"8337_CR39","doi-asserted-by":"publisher","first-page":"221ra15","DOI":"10.1126\/scitranslmed.3007653","volume":"6","author":"VI Sayin","year":"2014","unstructured":"Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6:221ra15 https:\/\/doi.org\/10.1126\/scitranslmed.3007653.","journal-title":"Sci Transl Med"},{"key":"8337_CR40","doi-asserted-by":"publisher","first-page":"8773","DOI":"10.1073\/pnas.1105941108","volume":"108","author":"AT Shaw","year":"2011","unstructured":"Shaw AT, Winslow MM, Magendantz M, Ouyang C, Dowdle J, Subramanian A, et al. Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc Natl Acad Sci USA. 2011;108:8773\u20138. https:\/\/doi.org\/10.1073\/pnas.1105941108.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8337_CR41","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013193","volume":"13","author":"Z Yang","year":"2021","unstructured":"Yang Z, Liang S-Q, Saliakoura M, Yang H, Vassella E, Konstantinidou G, et al. Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer. EMBO Mol Med. 2021;13:e13193. https:\/\/doi.org\/10.15252\/emmm.202013193.","journal-title":"EMBO Mol Med"},{"key":"8337_CR42","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41380-022-01937-5","volume":"28","author":"BK Unda","year":"2023","unstructured":"Unda BK, Chalil L, Yoon S, Kilpatrick S, Irwin C, Xing S, et al. Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome. Mol Psychiatry. 2023;28:1747\u201369. https:\/\/doi.org\/10.1038\/s41380-022-01937-5.","journal-title":"Mol Psychiatry"},{"key":"8337_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajhg.2018.01.006","volume":"102","author":"M Uddin","year":"2018","unstructured":"Uddin M, Unda BK, Kwan V, Holzapfel NT, White SH, Chalil L, et al. OTUD7A regulates neurodevelopmental phenotypes in the 15q13.3 microdeletion syndrome. Am J Hum Genet. 2018;102:278\u201395. https:\/\/doi.org\/10.1016\/j.ajhg.2018.01.006.","journal-title":"Am J Hum Genet"},{"key":"8337_CR44","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1042\/BST20230562","volume":"52","author":"CS Olie","year":"2024","unstructured":"Olie CS, O\u2019Brien DP, Jones HBL, Liang Z, Damianou A, Sur-Erdem I, et al. Deubiquitinases in muscle physiology and disorders. Biochem Soc Trans. 2024;52:1085\u201398. https:\/\/doi.org\/10.1042\/BST20230562.","journal-title":"Biochem Soc Trans"},{"key":"8337_CR45","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/ncb3218","volume":"17","author":"L Yuan","year":"2015","unstructured":"Yuan L, Lv Y, Li H, Gao H, Song S, Zhang Y, et al. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis. Nat Cell Biol. 2015;17:1169\u201381. https:\/\/doi.org\/10.1038\/ncb3218.","journal-title":"Nat Cell Biol"},{"key":"8337_CR46","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology, and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8337_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280\u201396. https:\/\/doi.org\/10.1038\/s41571-020-00462-0.","journal-title":"Nat Rev Clin Oncol"},{"key":"8337_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34 https:\/\/doi.org\/10.1186\/s13045-019-0720-y.","journal-title":"J Hematol Oncol"},{"key":"8337_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s43018-023-00653-5","volume":"5","author":"C Bruedigam","year":"2024","unstructured":"Bruedigam C, Porter AH, Song A, Vroeg In de Wei G, Stoll T, Straube J, et al. Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia. Nat Cancer. 2024;5:47\u201365. https:\/\/doi.org\/10.1038\/s43018-023-00653-5.","journal-title":"Nat Cancer"},{"key":"8337_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315541121","volume":"121","author":"H Li","year":"2024","unstructured":"Li H, Sun Y, Yao Y, Ke S, Zhang N, Xiong W, et al. USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Proc Natl Acad Sci USA. 2024;121:e2315541121. https:\/\/doi.org\/10.1073\/pnas.2315541121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8337_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22024-3","volume":"12","author":"L Garcia-Martinez","year":"2021","unstructured":"Garcia-Martinez L, Zhang Y, Nakata Y, Chan HL, Morey L. Epigenetic mechanisms in breast cancer therapy and resistance. Nat Commun. 2021;12:1786. https:\/\/doi.org\/10.1038\/s41467-021-22024-3.","journal-title":"Nat Commun"},{"key":"8337_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150:12\u201327. https:\/\/doi.org\/10.1016\/j.cell.2012.06.013.","journal-title":"Cell"},{"key":"8337_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","volume":"502","author":"F Paredes","year":"2021","unstructured":"Paredes F, Williams HC, San Martin A. Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021;502:133\u201342. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.020.","journal-title":"Cancer Lett"},{"key":"8337_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cmet.2023.12.003","volume":"36","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wu M-J, Lu W-C, Li Y-C, Chang CJ, Yang J-Y. Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer. Cell Metab. 2024;36:193\u2013.e8. https:\/\/doi.org\/10.1016\/j.cmet.2023.12.003.","journal-title":"Cell Metab"},{"key":"8337_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308045","volume":"11","author":"J Huang","year":"2024","unstructured":"Huang J, Yin Q, Wang Y, Zhou X, Guo Y, Tang Y, et al. EZH2 inhibition enhances PD-L1 protein stability through USP22-mediated deubiquitination in colorectal cancer. Adv Sci. 2024;11:e2308045. https:\/\/doi.org\/10.1002\/advs.202308045.","journal-title":"Adv Sci"},{"key":"8337_CR56","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","volume":"8","author":"J Yang","year":"2023","unstructured":"Yang J, Xu J, Wang W, Zhang B, Yu X, Shi S. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2023;8:210 https:\/\/doi.org\/10.1038\/s41392-023-01480-x.","journal-title":"Signal Transduct Target Ther"},{"key":"8337_CR57","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","volume":"30","author":"S-O Lim","year":"2016","unstructured":"Lim S-O, Li C-W, Xia W, Cha J-H, Chan L-C, Wu Y, et al. Deubiquitination and stabilization of PD-L1 by CSN5. Cancer Cell. 2016;30:925\u201339. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.010.","journal-title":"Cancer Cell"},{"key":"8337_CR58","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:70 https:\/\/doi.org\/10.1038\/s41392-023-01332-8.","journal-title":"Signal Transduct Target Ther"},{"key":"8337_CR59","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/HEP.0000000000000599","volume":"79","author":"S Chen","year":"2024","unstructured":"Chen S, Liao C, Hu H, Liao J, Chen Z, Li S, et al. Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC. Hepatology. 2024;79:780\u201397. https:\/\/doi.org\/10.1097\/HEP.0000000000000599.","journal-title":"Hepatology"},{"key":"8337_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01645-2","volume":"21","author":"R Bai","year":"2022","unstructured":"Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol Cancer. 2022;21:177. https:\/\/doi.org\/10.1186\/s12943-022-01645-2.","journal-title":"Mol Cancer"},{"key":"8337_CR61","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","volume":"8","author":"D Denk","year":"2022","unstructured":"Denk D, Greten FR. Inflammation: the incubator of the tumor microenvironment. Trends Cancer. 2022;8:901\u201314. https:\/\/doi.org\/10.1016\/j.trecan.2022.07.002.","journal-title":"Trends Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08337-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08337-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08337-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:53:16Z","timestamp":1769532796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08337-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8337"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08337-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors agree with the content of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Guide for the Care and Use of Laboratory Animals standards were followed in all animal research procedures. This study adheres to internationally accepted standards for animal research, following the 3Rs principle. The ARRIVE guidelines were employed for reporting experiments involving live animals, promoting ethical research practices.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Animal welfare and ethical review of the experiments were conducted by the Institutional Animal Care and Use Committee of the Nanjing Medical University (IACUC-2404053). Patient ethics were approved by the Ethics Committee of Jiangsu Cancer Hospital (KY-2024-028). Relevant documentation is included in the supplementary material.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"112"}}